Table 1.
Influences of TCM treatment on immune factors in COVID-19 convalescents
| Indices (unit) | Reference range | Non-treatment (n = 425) | TCM treatment (n = 143) | P value |
|---|---|---|---|---|
| WBC count (109/L) | 3.5-9.5 | 6.01±1.38 | 5.68±1.05**↓ | 0.0078 |
| LYM count (109/L) | 1.1-3.2 | 1.84±0.55 | 1.73±0.43*↓ | 0.0234 |
| MON count (109/L) | 0.1-0.6 | 0.49±0.17 | 0.44±0.12**↓ | 0.0033 |
| NEUT count (109/L) | 1.8-6.3 | 3.52±1.17 | 3.32±0.90 | 0.0734 |
| EOS count (109/L) | 0.02-0.52 | 0.13±0.09 | 0.15±0.14 | 0.1286 |
| BASO count (109/L) | 0-0.06 | 0.04±0.02 | 0.04±0.01 | 0.8098 |
| IL-6 (pg/mL) | <7 | 18.31±54.06 | 4.47±17.53*↓ | 0.0113 |
| Hs-CRP (mg/dL) | 0-0.5 | 0.42±0.69 | 0.58±0.64 | 0.080 |
| SAA (mg/L) | 0-10 | 6.20±5.51 | 6.06±8.82 | 0.8293 |
| PCT1 (ng/mL) | 0-0.5 | 0.04±0.04 | 0.02±0.03*↓ | 0.0372 |
Continuous variables were analyzed using one-way ANOVA (Tamhane's T2) test. *P<0.05, **P<0.01 vs non-treatment group. The symbols ↓ and ↑ represented significantly higher or lower.